行为参与和激活模型研究 (BEAMS):对 2 型糖尿病患者中数字健康技术采用者和非采用者的潜类分析。

IF 3.6 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr
{"title":"行为参与和激活模型研究 (BEAMS):对 2 型糖尿病患者中数字健康技术采用者和非采用者的潜类分析。","authors":"John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr","doi":"10.1093/tbm/ibae034","DOIUrl":null,"url":null,"abstract":"<p><p>Many people with Type 2 diabetes (T2D) who could benefit from digital health technologies (DHTs) are either not using DHTs or do use them, but not for long enough to reach their behavioral or metabolic goals. We aimed to identify subgroups within DHT adopters and non-adopters and describe their unique profiles to better understand the type of tailored support needed to promote effective and sustained DHT use across a diverse T2D population. We conducted latent class analysis of a sample of adults with T2D who responded to an internet survey between December 2021 and March 2022. We describe the clinical and psychological characteristics of DHT adopters and non-adopters, and their attitudes toward DHTs. A total of 633 individuals were characterized as either DHT \"Adopters\" (n = 376 reporting any use of DHT) or \"Non-Adopters\" (n = 257 reporting never using any DHT). Within Adopters, three subgroups were identified: 21% (79/376) were \"Self-managing Adopters,\" who reported high health activation and self-efficacy for diabetes management, 42% (158/376) were \"Activated Adopters with dropout risk,\" and 37% (139/376) were \"Non-Activated Adopters with dropout risk.\" The latter two subgroups reported barriers to using DHTs and lower rates of intended future use. Within Non-Adopters, two subgroups were identified: 31% (79/257) were \"Activated Non-Adopters,\" and 69% (178/257) were \"Non-Adopters with barriers,\" and were similarly distinguished by health activation and barriers to using DHTs. Beyond demographic characteristics, psychological, and clinical factors may help identify different subgroups of Adopters and Non-Adopters.</p>","PeriodicalId":48679,"journal":{"name":"Translational Behavioral Medicine","volume":" ","pages":"491-498"},"PeriodicalIF":3.6000,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282572/pdf/","citationCount":"0","resultStr":"{\"title\":\"Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes.\",\"authors\":\"John D Piette, Keni C S Lee, Hayden B Bosworth, Diana Isaacs, Christian J Cerrada, Raghu Kainkaryam, Jan Liska, Felix Lee, Adee Kennedy, David Kerr\",\"doi\":\"10.1093/tbm/ibae034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Many people with Type 2 diabetes (T2D) who could benefit from digital health technologies (DHTs) are either not using DHTs or do use them, but not for long enough to reach their behavioral or metabolic goals. We aimed to identify subgroups within DHT adopters and non-adopters and describe their unique profiles to better understand the type of tailored support needed to promote effective and sustained DHT use across a diverse T2D population. We conducted latent class analysis of a sample of adults with T2D who responded to an internet survey between December 2021 and March 2022. We describe the clinical and psychological characteristics of DHT adopters and non-adopters, and their attitudes toward DHTs. A total of 633 individuals were characterized as either DHT \\\"Adopters\\\" (n = 376 reporting any use of DHT) or \\\"Non-Adopters\\\" (n = 257 reporting never using any DHT). Within Adopters, three subgroups were identified: 21% (79/376) were \\\"Self-managing Adopters,\\\" who reported high health activation and self-efficacy for diabetes management, 42% (158/376) were \\\"Activated Adopters with dropout risk,\\\" and 37% (139/376) were \\\"Non-Activated Adopters with dropout risk.\\\" The latter two subgroups reported barriers to using DHTs and lower rates of intended future use. Within Non-Adopters, two subgroups were identified: 31% (79/257) were \\\"Activated Non-Adopters,\\\" and 69% (178/257) were \\\"Non-Adopters with barriers,\\\" and were similarly distinguished by health activation and barriers to using DHTs. Beyond demographic characteristics, psychological, and clinical factors may help identify different subgroups of Adopters and Non-Adopters.</p>\",\"PeriodicalId\":48679,\"journal\":{\"name\":\"Translational Behavioral Medicine\",\"volume\":\" \",\"pages\":\"491-498\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282572/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Behavioral Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/tbm/ibae034\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Behavioral Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/tbm/ibae034","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

许多可以从数字健康技术(DHT)中获益的 2 型糖尿病(T2D)患者要么没有使用 DHT,要么虽然使用了,但使用时间不够长,无法达到行为或代谢目标。我们旨在识别数字健康技术采用者和未采用者中的亚群,并描述他们的独特特征,以便更好地了解在不同的 T2D 群体中促进有效和持续使用数字健康技术所需的定制支持类型。我们对 2021 年 12 月至 2022 年 3 月间参与互联网调查的 T2D 成人样本进行了潜类分析。我们描述了DHT采用者和未采用者的临床和心理特征,以及他们对DHT的态度。共有 633 人被归类为 DHT "采用者"(376 人报告使用过 DHT)或 "未采用者"(257 人报告从未使用过 DHT)。在 "采用者 "中,发现了三个亚群:21%(79/376)为 "自我管理采用者",他们报告说在糖尿病管理方面具有较高的健康激活度和自我效能;42%(158/376)为 "激活采用者,但有放弃风险";37%(139/376)为 "非激活采用者,但有放弃风险"。后两个亚群报告了使用 DHTs 的障碍和较低的未来预期使用率。在 "非采用者 "中,发现了两个亚群:31%(79/257)为 "已激活的非放弃者",69%(178/257)为 "有障碍的非放弃者",他们在健康激活和使用 DHTs 的障碍方面也有类似的区别。除人口统计学特征外,心理和临床因素也有助于识别采用者和非采用者中的不同亚群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes.

Many people with Type 2 diabetes (T2D) who could benefit from digital health technologies (DHTs) are either not using DHTs or do use them, but not for long enough to reach their behavioral or metabolic goals. We aimed to identify subgroups within DHT adopters and non-adopters and describe their unique profiles to better understand the type of tailored support needed to promote effective and sustained DHT use across a diverse T2D population. We conducted latent class analysis of a sample of adults with T2D who responded to an internet survey between December 2021 and March 2022. We describe the clinical and psychological characteristics of DHT adopters and non-adopters, and their attitudes toward DHTs. A total of 633 individuals were characterized as either DHT "Adopters" (n = 376 reporting any use of DHT) or "Non-Adopters" (n = 257 reporting never using any DHT). Within Adopters, three subgroups were identified: 21% (79/376) were "Self-managing Adopters," who reported high health activation and self-efficacy for diabetes management, 42% (158/376) were "Activated Adopters with dropout risk," and 37% (139/376) were "Non-Activated Adopters with dropout risk." The latter two subgroups reported barriers to using DHTs and lower rates of intended future use. Within Non-Adopters, two subgroups were identified: 31% (79/257) were "Activated Non-Adopters," and 69% (178/257) were "Non-Adopters with barriers," and were similarly distinguished by health activation and barriers to using DHTs. Beyond demographic characteristics, psychological, and clinical factors may help identify different subgroups of Adopters and Non-Adopters.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Translational Behavioral Medicine
Translational Behavioral Medicine PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -
CiteScore
6.80
自引率
0.00%
发文量
87
期刊介绍: Translational Behavioral Medicine publishes content that engages, informs, and catalyzes dialogue about behavioral medicine among the research, practice, and policy communities. TBM began receiving an Impact Factor in 2015 and currently holds an Impact Factor of 2.989. TBM is one of two journals published by the Society of Behavioral Medicine. The Society of Behavioral Medicine is a multidisciplinary organization of clinicians, educators, and scientists dedicated to promoting the study of the interactions of behavior with biology and the environment, and then applying that knowledge to improve the health and well-being of individuals, families, communities, and populations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信